We are live on ! Find out more
HALO icon

Halozyme

511 hedge funds and large institutions have $5.86B invested in Halozyme in 2024 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 180 increasing their positions, 178 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more call options, than puts

Call options by funds: $36.9M | Put options by funds: $12.9M

10% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 83

1% more repeat investments, than reductions

Existing positions increased: 180 | Existing positions reduced: 178

0% more funds holding

Funds holding: 511 → 511 (0)

2.53% less ownership

Funds ownership: 98.89% → 96.36% (-2.5%)

16% less capital inflows, than outflows

Capital inflows: $671M | Capital outflows: $803M

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
511
Holders Change
–
Holders Change %
0%
% of All Funds
6.7%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
91
Increased
180
Reduced
178
Closed
83
Calls
$36.9​M
Puts
$12.9​M
Net Calls
+$24​M
Net Calls Change
+$13.6​M

HALO Hedge Fund Activity: Q4 2024 in Review

511 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2024, worth a combined $5.86B — down 18% from $7.17B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new HALO positions and 83 closed out — a net gain of 8 holders — while 180 added to existing stakes and 178 trimmed.

The largest buyer was Bank of America, adding an estimated $70.7M. The largest seller was Artisan Partners, cutting an estimated $90.3M.

  • 511 institutional investors held Halozyme (HALO) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $5.86B of Halozyme stock for Q4 2024, down 18% quarter-over-quarter.
  • 91 funds opened new Halozyme positions in Q4 2024 and 83 closed out, a net change of +8 holders.
  • The largest Halozyme buyer in Q4 2024 was Bank of America, an estimated $70.7M added.
  • The largest Halozyme seller in Q4 2024 was Artisan Partners, an estimated $90.3M sold.

Based on aggregated 13F filings for Q4 2024.